🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Can AI make medical info easier to understand? A new NYU Langone Health study says yes. Tools like ChatGPT improved complex patient education materials—bringing them closer to the 6th-grade reading level recommended for accessibility. Read the full article: bit.ly/3Fm7IlQ

An asymptomatic 54-year-old woman was diagnosed with a 2.1 cm urethral diverticulum on MRI. Despite no symptoms, she opted for surgery to prevent future complications. Outcome: full recovery with continence preserved. Read more: bit.ly/4jets0Z

Dr. J. Thomas Roland Jr. and NYU Langone lead pediatric ABI care, helping children without a cochlear nerve. With 79% improving, research continues to enhance surgery and programming. Full interview: bit.ly/3HbHVxn

At #ASCO25, NYU Langone experts share new findings in mCRPC drug combos (Dr. Wise), personalized breast cancer care from the ELEVATE trial (Dr. Chan), and IL-6 therapies in melanoma (Dr. Mehnert). See the full list of presenters ➡️ bit.ly/4kAuDbX

New in nature: Cysteine deprivation led to 30% weight loss in mice by disrupting key energy pathways and triggering fat-burning responses. Findings reveal a novel metabolic mechanism with potential implications for future obesity therapies. Read more: nature.com/articles/s4158…

A 13-year-old with congenital hydronephrosis presents with hematuria after trauma. Imaging revealed a 26 cm kidney. A robot-assisted nephrectomy removed 3+ liters of fluid—highlighting the value of long-term follow-up in pediatric urology. Read more: bit.ly/43IXIeI

Congratulations to Mark Yarmarkovich, PhD, recipient of the 2025 Pershing Square Sohn Cancer Prize, and Neil Vasan, MD, PhD, honored with the 2025 Conquer Cancer Award for advancing targeted therapies in oncology. #CancerResearch #NYULangone

Why do some melanoma patients respond to immunotherapy while others don’t? Our new study links inherited mitochondrial DNA differences to treatment response, offering insights for personalized cancer care. ✍️ nature Perlmutter Cancer Center at NYU Langone Health 🔗 Read more: nature.com/articles/s4159…

At #ASCO25, Dr. Nancy Chan shares updates on the ELEVATE trial, a study exploring L-acestrin + targeted therapies for breast cancer. No new toxicity signals. Green light for Phase 2. Learn more: bit.ly/3SKE1hv

At #ASCO2025, NYU Grossman med student Lucas Mavromatis presented data linking GLP-1 receptor agonists to a 7% lower incidence of obesity-related cancers—compared to weight-neutral DPP-4 inhibitors. #GLP1 #ObesityResearch #CancerPrevention #NYULangone

Can we boost response & reduce toxicity in #melanoma treatment? At #ASCO25, Dr. Janice Mehnert shares Phase 2 trial results: ✅ 63.6% response rate ✅ Fewer severe side effects using IL-6 blocker + checkpoint inhibitors   Next stop: randomized Phase 2.

“Our early lecanemab data showed short-term clinical improvement—something we didn’t expect,” says NYU Langone neurology resident Phil Kuball, MD, who presented at #AAN2024. As #BrainAwarenessMonth continues, we're proud to support emerging voices in Alzheimer’s research. 🧠

Researchers at NYU Langone Health + @PerlmutterCC found why some melanomas with NF1 mutations resist immunotherapy and how EGFR inhibitors, already used in other cancers, may help. Read more: bit.ly/40e4BDF

Can a smartphone app detect psoriatic arthritis flare? NYU Langone researchers found Psorcast app can capture skin and joint symptoms with clinical accuracy, without an office visit. 📲 Read the study: bit.ly/4emgkpM #PsoriaticDisease #HealthTech

🎙️ Celebrating 20 years of innovation at NYU Langone Health’s Voice Center. From pioneering office-based procedures to launching an in-office fluoroscopy suite, the team leads in vocal, airway, and swallowing care. Read more: bit.ly/44e4sBw

Can wearables predict prostate cancer side effects? Dr. Andrew Laccetti uses Fitbits, surveys & predictive modeling to improve life on hormone therapy—and building systems to support oncologists in the community. Read more: bit.ly/4ncq5dU

NYU Langone welcomes Dr. Michael Dolinger as Director of Pediatric IBD. He’s leading the way with intestinal ultrasound—a fast, noninvasive tool transforming care for kids with Crohn’s and colitis. Read more: bit.ly/4k4JHOu

NYU Langone’s three-year rheumatology fellowship, includes a research track combining clinical training with dedicated time for lab work, clinical studies, and publishing—preparing fellows for academic leadership. Head to Physician Focus to read more: bit.ly/4k6eKtd

Discover how NYU Grossman School of Medicine’s Dr. Michael E. Pacold turned a basic question about oxygen into a potential cure for a rare pediatric disease. #BehindTheBreakthrough Watch the latest episode: bit.ly/45UNk6e Head to nature for the full study: go.nature.com/45W5W5R

New research suggests a more targeted way to quiet harmful T cells in autoimmune disease, without broadly weakening the immune system. 🔬Findings published in Cell: bit.ly/44ruOBl #AutoimmuneResearch #Immunotherapy #Type1Diabetes #MS #Hepatitis